First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.55 USD 4.73% Market Closed
Updated: May 29, 2024

Interpace Biosciences Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Interpace Biosciences Inc
Total Liabilities Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Interpace Biosciences Inc
OTC:IDXG
Total Liabilities
$26.7m
CAGR 3-Years
-4%
CAGR 5-Years
8%
CAGR 10-Years
-2%
DaVita Inc
NYSE:DVA
Total Liabilities
$16.5B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Quest Diagnostics Inc
NYSE:DGX
Total Liabilities
$7.5B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
3%
CVS Health Corp
NYSE:CVS
Total Liabilities
$175.8B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
18%
Cigna Corp
NYSE:CI
Total Liabilities
$111.9B
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
10%
Laboratory Corporation of America Holdings
NYSE:LH
Total Liabilities
$8.6B
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
7%

See Also

What is Interpace Biosciences Inc's Total Liabilities?
Total Liabilities
26.7m USD

Based on the financial report for Mar 31, 2024, Interpace Biosciences Inc's Total Liabilities amounts to 26.7m USD.

What is Interpace Biosciences Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
-2%

Over the last year, the Total Liabilities growth was -16%. The average annual Total Liabilities growth rates for Interpace Biosciences Inc have been -4% over the past three years , 8% over the past five years , and -2% over the past ten years .